Affiliations 

  • 1 British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
  • 2 Institute for Medical Research, National Institute of Health, Ministry of Health, Kuala Lumpur, Malaysia
  • 3 UKM Medical Molecular Biological Institute, Kuala Lumpur, Malaysia
  • 4 National Heart Institute, Kuala Lumpur, Malaysia
  • 5 Department of Cardiology, Hospital Serdang, Selangor, Malaysia
  • 6 Jeffery Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Malaysia
  • 7 Department of Cardiology, Sarawak Heart Centre, Kota Samarahan, Malaysia
  • 8 Department of Cardiology, Hospital Pulau Pinang, Pulau Pinang, Malaysia
  • 9 Department of Cardiology, Hospital Sultanah Bahiyah, Kedah, Malaysia
  • 10 Department of Cardiology, Hospital Sultanah Aminah, Johor, Malaysia
  • 11 Department of Cardiology & Clinical Research Centre, Hospital Queen Elizabeth II, Sabah, Malaysia
  • 12 Department of General Medicine, Hospital Tengku Ampuan Rahimah, Selangor, Malaysia
  • 13 Department of General Medicine & Clinical Research Centre, Hospital Melaka, Melaka, Malaysia
  • 14 Department of General Medicine, Hospital Raja Permaisuri Bainun, Perak, Malaysia
  • 15 Department of General Medicine, Hospital Shah Alam, Selangor, Malaysia
  • 16 Department of General Medicine, Hospital Tuanku Fauziah, Perlis, Malaysia
  • 17 Department of Cardiology, Hospital Sultanah Nur Zahirah, Terengganu, Malaysia
  • 18 Department of General Medicine, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
  • 19 Department of Cardiology, Hospital Tengku Ampuan Afzan, Pahang, Malaysia
  • 20 Department of General Medicine, Hospital Sungai Buloh, Selangor, Malaysia
  • 21 National Heart Foundation Hospital & Research Institute, Mirpur, Dhaka, Bangladesh
JMIR Res Protoc, 2022 Feb 10;11(2):e31885.
PMID: 35142634 DOI: 10.2196/31885

Abstract

BACKGROUND: Although the burden of premature myocardial infarction (MI) is high in Malaysia, direct evidence on the determinants of MI in this multi-ethnic population remains sparse.

OBJECTIVE: The Malaysian Acute Vascular Events Risk (MAVERIK) study is a retrospective case-control study established to investigate the genomic, lipid-related, and other determinants of acute MI in Malaysia. In this paper, we report the study protocol and early results.

METHODS: By June 2019, we had enrolled approximately 2500 patients with their first MI and 2500 controls without cardiovascular disease, who were frequency-matched by age, sex, and ethnicity, from 17 hospitals in Malaysia. For each participant, serum and whole blood have been collected and stored. Clinical, demographic, and behavioral information has been obtained using a 200-item questionnaire.

RESULTS: Tobacco consumption, a history of diabetes, hypertension, markers of visceral adiposity, indicators of lower socioeconomic status, and a family history of coronary disease were more prevalent in cases than in controls. Adjusted (age and sex) logistic regression models for traditional risk factors indicated that current smoking (odds ratio [OR] 4.11, 95% CI 3.56-4.75; P30 kg/m2; OR 1.19, 95% CI 1.05-1.34; P=.009) were associated with MI in age- and sex-adjusted models.

CONCLUSIONS: The MAVERIK study can serve as a useful platform to investigate genetic and other risk factors for MI in an understudied Southeast Asian population. It should help to hasten the discovery of disease-causing pathways and inform regionally appropriate strategies that optimize public health action.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/31885.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.